Skip to main content
ConductScienceScienceDex

Daniel A. Haber

NIH Rank #5928
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Mentor

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1882057Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$2.2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#5,928
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Daniel A. Haber. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Daniel A. Haber as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA255602-05R01
    High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
    Massachusetts General Hospital
    $647.6K
    award amount
  • 5T32CA071345-28T32
    Training Program in Cancer Biology and Therapeutics
    Massachusetts General Hospital
    $633.5K
    award amount
  • 5R01CA260304-05R01
    Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
    Massachusetts General Hospital
    $453.4K
    award amount
  • 5R01CA129933-18R01
    Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells
    Massachusetts General Hospital
    $420K
    award amount

Award organization

Organizations that administered FY2025 awards listing Daniel A. Haber as a PI.

FY2025 award administered by Massachusetts General Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4944
  6. 2024
    Entered Top 25% Nationally
    Ranked #4944
  7. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Daniel A. Haber.

Mehmet Toner
Massachusetts General Hospital
4
shared awards
Shyamala Maheswaran
Massachusetts General Hospital
4
shared awards
Lecia V. Sequist
Massachusetts General Hospital
3
shared awards

Explore further

Find collaborators for Daniel A. Haber

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →